Dr Richard Leighton Peatman, PHARMD | |
16893 Placer Hills Rd, Meadow Vista, CA 95722-9531 | |
(530) 878-7440 | |
(530) 878-2470 |
Full Name | Dr Richard Leighton Peatman |
---|---|
Gender | Male |
Speciality | Physician Assistant |
Location | 16893 Placer Hills Rd, Meadow Vista, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558366872 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1835P1200X | Pharmacist - Pharmacotherapy | 32014 (California) | Primary |
363A00000X | Physician Assistant | PA10712 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Richard Leighton Peatman, PHARMD 875 Spruce Dr, Meadow Vista, CA 95722-9503 Ph: (530) 878-8864 | Dr Richard Leighton Peatman, PHARMD 16893 Placer Hills Rd, Meadow Vista, CA 95722-9531 Ph: (530) 878-7440 |
News Archive
Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.
Curemark LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that it has been awarded a grant by the United States government under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product CM-AT for autism. CM-AT is presently in Phase III clinical trials at 18 sites around the US.
The Royal Society of Canada, the U.S. National Academy of Sciences and other scientific research organizations from around the world released a statement on Tuesday with recommendations for G8 countries on how to improve the health of women and children worldwide, the Toronto Star reports.
A new study conducted by researchers at Yonsei University College of Medicine, Korea, suggests that while having coronavirus disease 2019 (COVID-19) during pregnancy has little effect on fetal or neonatal mortality, it can be associated with premature birth and sometimes severe outcomes for mother and baby, including death.
› Verified 9 days ago